Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome.
about
Drugs for anovulatory infertility in polycystic ovary syndromeClomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysisLong versus short course treatment with metformin and clomiphene citrate for ovulation induction in women with PCOSLong versus short course treatment with Metformin and Clomiphene Citrate for ovulation induction in women with PCOSTherapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome.Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study.A retrospective survey of quality of reporting on randomized controlled trials of metformin for polycystic ovary syndromeInterventional studies for polycystic ovarian syndrome in children and adolescents.Comparative evaluation of pregnancy outcome in gonadotrophin-clomiphene combination vs clomiphene alone in polycystic ovarian syndrome and unexplained infertility-A prospective clinical trial.Impact of metformin on reproductive tissues: an overview from gametogenesis to gestationClomiphene citrate--end of an era? A mini-review.The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence.State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).Polycystic ovary syndrome: chemical pharmacotherapy.Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndromeMetformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review.Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis.Commonly used fertility drugs, a diet supplement, and stress force AMPK-dependent block of stemness and development in cultured mammalian embryos.Polycystic ovary syndrome and insulin: our understanding in the past, present and future.Clinical outcomes of ovulation induction with metformin, clomiphene citrate and human menopausal gonadotrophin in polycystic ovary syndrome.Metformin in women with PCOS, pros.Contemporary approaches to the management of polycystic ovary syndrome.
P2860
Q22242103-4D90F6DC-E923-4DEC-A8CD-A26908D107E9Q22242629-F481BAF4-11EA-4DC6-A2FC-7780A41B1AF2Q24198828-E8049E29-18B1-4862-9BCF-935DEDE77DD9Q24242205-62F63D37-CA0C-4522-B67A-7858B86D5B8CQ33230782-BBFD3627-DDBE-419A-B959-5F70D8590484Q33447184-4138A208-3FE5-45BD-BDB8-59D685041D0DQ33614259-8AE64BC4-92E6-4F70-B9F3-C0437BF328C0Q33996662-948A83AA-FF75-45FC-9429-7A8C03D564B2Q34268679-55081A2D-757E-4179-8BE2-230D194D5EB4Q34357928-2C7B2BCE-F4B7-4154-949C-F5488A3142A5Q34557430-58D852E3-1B79-493A-AB70-479CB0D905EAQ34998688-140BFD85-CD89-4C4F-8ACA-8E2565E4D3AFQ35233754-C93016EB-72A9-48FB-8393-BAD1D8FA8741Q35639510-68AF062C-8D2B-4AAF-9FB0-0218195E894AQ36366167-85CF9A46-907E-46FB-A501-5DEE946EB677Q36554670-E987E5D9-715E-4D72-A0ED-C99816991EECQ36721550-71B3CB29-E9FE-4DCD-9BC8-DE220C0374AFQ37570577-EAB78C47-9A5F-413D-8BB0-A1AB97F278CBQ38003834-A9E3DA2C-251E-4AA0-89B7-9B5F8D242776Q38292317-03025E15-0F16-4FBB-81E0-1E894A4095C2Q38380065-AEA140BD-1055-4345-BA7F-3345602574CEQ42868397-93CF9C16-2ED4-4D99-BB9A-A8CE834CD33BQ43852376-A212D2A1-F358-4FB7-9291-254DAB9A9F4FQ52606007-F1D69F78-9E70-4B34-8F39-70152746B73E
P2860
Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Insulin-sensitizing agents as ...... h polycystic ovarian syndrome.
@ast
Insulin-sensitizing agents as ...... h polycystic ovarian syndrome.
@en
Insulin-sensitizing agents as ...... h polycystic ovarian syndrome.
@nl
type
label
Insulin-sensitizing agents as ...... h polycystic ovarian syndrome.
@ast
Insulin-sensitizing agents as ...... h polycystic ovarian syndrome.
@en
Insulin-sensitizing agents as ...... h polycystic ovarian syndrome.
@nl
prefLabel
Insulin-sensitizing agents as ...... h polycystic ovarian syndrome.
@ast
Insulin-sensitizing agents as ...... h polycystic ovarian syndrome.
@en
Insulin-sensitizing agents as ...... h polycystic ovarian syndrome.
@nl
P356
P1433
P1476
Insulin-sensitizing agents as ...... h polycystic ovarian syndrome.
@en
P2093
George A Wells
Sonya Kashyap
P304
P356
10.1093/HUMREP/DEH440
P407
P577
2004-09-09T00:00:00Z